| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/13/1997 | CA2228176A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | CA2227972A1 Mocarhagin, a cobra venom protease and therapeutic uses thereof |
| 02/13/1997 | CA2227364A1 Cyclic peptide anti-fungal agents |
| 02/13/1997 | CA2224909A1 Ha-2 antigenic peptide |
| 02/13/1997 | CA2224894A1 The h-y antigen |
| 02/13/1997 | CA2223872A1 The preparation of .alpha.-(n,n-dialkyl)-amino (sic) carboxamides |
| 02/12/1997 | EP0604552B1 Method of synthesizing diverse collections of oligomers |
| 02/12/1997 | EP0564588B1 Hexapeptide anaphylatoxin-receptor ligands |
| 02/12/1997 | EP0470184B1 Antibodies specific for cd4-binding domain of hiv |
| 02/12/1997 | CN1142832A CS-1 peptidomimetics, compositions and methods of using the same |
| 02/11/1997 | US5602231 Process for making peptides |
| 02/11/1997 | US5602230 Peptide inhibitors of selectin binding |
| 02/11/1997 | US5602229 Pentapeptide antibiotics |
| 02/11/1997 | US5602100 Analgesics, treating gastrointestinal disorders |
| 02/11/1997 | US5602099 δ opioid receptor antagonists |
| 02/11/1997 | US5602097 Synthetic antibiotics |
| 02/11/1997 | US5602031 DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them |
| 02/11/1997 | US5602003 N-acetylglucosaminyltransferase V gene |
| 02/11/1997 | US5601990 Methods of diagnosing colorectal tumors and metastasis thereof |
| 02/11/1997 | US5601973 Polypeptides for diagnostic identifying specific antibodies |
| 02/11/1997 | US5601821 Histamine releasing peptide |
| 02/11/1997 | CA2054212C Method for polymerization of epoxide compounds |
| 02/06/1997 | WO1997004085A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 02/06/1997 | WO1997004005A2 Cyclosporin derivatives with anti-hiv effect |
| 02/06/1997 | WO1997004004A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 02/06/1997 | WO1996040770A3 Anti-fungal d-amino acid histatin-based peptides |
| 02/06/1997 | CA2227198A1 Cysteine protease inhibitors for use in treatment of ige mediated allergic diseases |
| 02/05/1997 | EP0757058A1 Cyclic peptide anti-fungal agents |
| 02/05/1997 | EP0756605A1 Peptides as therapeutic agents for the treatment of auto-immune diseases |
| 02/05/1997 | EP0756603A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells |
| 02/05/1997 | EP0756490A1 Human bone stimulating factor |
| 02/05/1997 | EP0756449A1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides |
| 02/05/1997 | EP0573499B1 Process for the phosphorylation of insulin and product produced thereby |
| 02/04/1997 | US5599903 Glutathione analogs and paralog panels comprising glutathione mimics |
| 02/04/1997 | US5599902 Cancer inhibitory peptides |
| 02/04/1997 | US5599901 Oligopeptides useful as affinity chromatography supports for the separation and purification of proteins; variable charge distribution, hydrophobicity, molecular rigidity and helical conformation propensity |
| 02/04/1997 | US5599791 Bactericide active against gramnegative and grampositive bacteria |
| 02/04/1997 | US5599708 Stimulate formation of osteoclast bone cells; treatment of bone marrow disorders |
| 02/04/1997 | US5599678 Antibodies which react with fibrinogen fragments E1, E2 and E3 and methods of their use |
| 02/04/1997 | US5599542 Diagnosis, treatment and vaccine for malaria; induction of antibodies that attack plasmodium in the schizont stage |
| 01/30/1997 | WO1997003094A1 Cell adhesion inhibitors |
| 01/30/1997 | WO1996041815A3 CONJUGATES OF αMSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 01/30/1997 | WO1996039425A3 Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity |
| 01/30/1997 | DE19527575A1 Verfahren zur Herstellung von peptidischer Wirkstoffe Process for the preparation of active substances of peptidic |
| 01/30/1997 | DE19527574A1 Verfahren zur Herstellung vona-(N,N-Dialkyl)-aminocaarbonsäureamiden -aminocaarbonsäureamiden Process for preparing vona- (N, N-dialkyl) |
| 01/30/1997 | CA2226868A1 Cell adhesion inhibitors |
| 01/29/1997 | EP0755941A2 Polypeptide and process for measuring living body components using the same |
| 01/29/1997 | EP0755408A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 01/29/1997 | EP0755404A1 Tachykinin antagonists |
| 01/29/1997 | EP0644772A4 Opioid peptides. |
| 01/29/1997 | EP0493446B1 Treatment of autoimmune disease |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141594A Method for identifying individuals suffering from cellular abnormality |
| 01/28/1997 | US5597894 Multi-tyrosinated somatostatin analogs |
| 01/28/1997 | US5597803 Bradykinin peptides with modifications at the N terminus |
| 01/28/1997 | US5597693 Hormone response element compositions and assay |
| 01/23/1997 | WO1997002344A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 01/23/1997 | WO1997002289A1 Peptide inhibitors of fibronectine |
| 01/23/1997 | WO1997002287A1 Parevins and tachytegrins |
| 01/23/1997 | WO1997002282A1 Photoreactive peptide derivatives |
| 01/23/1997 | WO1997001959A1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits |
| 01/23/1997 | WO1996040944A3 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 01/23/1997 | WO1996040940A3 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 01/23/1997 | CA2226121A1 Parevins and tachytegrins |
| 01/23/1997 | CA2225636A1 Photoreactive peptide derivatives |
| 01/23/1997 | CA2223825A1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 01/22/1997 | EP0754704A2 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 01/22/1997 | EP0754302A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 01/22/1997 | CN1141002A Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 01/21/1997 | US5596078 Synthesis of cyclic peptides |
| 01/21/1997 | US5595887 Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment |
| 01/21/1997 | US5595885 Matrix metalloproteinase inhibitor peptides |
| 01/21/1997 | US5595877 Methods of producing nucleic acid ligands |
| 01/21/1997 | CA1338867C Derivatives and precursors of captopril and its analogues and methods for preparing captopril and its analogues therefrom |
| 01/21/1997 | CA1338860C Radiolabelling of proteins |
| 01/19/1997 | CA2181109A1 Polypeptide and process for measuring living body components using the same |
| 01/16/1997 | WO1997001576A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 01/16/1997 | WO1997001575A1 Substance wf16616, process for production thereof, and use thereof |
| 01/16/1997 | WO1997001350A1 Cd4-derived peptides that inhibit immune responses |
| 01/16/1997 | WO1996034113A3 Methods for the identification of farnesyltransferase inhibitors |
| 01/16/1997 | DE19525784A1 Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) Autoreactive peptides from human glutamic acid decarboxylase (GAD) |
| 01/16/1997 | CA2226017A1 Cd4-derived peptides that inhibit immune responses |
| 01/16/1997 | CA2197861A1 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 01/15/1997 | EP0753059A1 Peptide production as fusion protein in transgenic mammal milk |
| 01/15/1997 | EP0753007A1 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same |
| 01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
| 01/15/1997 | EP0753005A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides |
| 01/15/1997 | EP0752876A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 01/15/1997 | EP0752873A1 Labelled peptide compounds |
| 01/14/1997 | US5594115 Fusion protein containing polypeptides and metal chelating peptide |
| 01/14/1997 | US5594105 Peptide inhibitors of mitogenesis and motogenesis |
| 01/14/1997 | US5594102 Hydrolysis to form antibiotics |
| 01/14/1997 | US5593965 Anti-tumor effects of GnRH-III |
| 01/14/1997 | US5593960 Producing cyclomarin a from fermentation of streptomyces |
| 01/14/1997 | US5593866 Cationic peptides and method for production |
| 01/14/1997 | CA2020062C Antibiotic agent |
| 01/14/1997 | CA1338848C Hydrogenated derivatives of antibiotic a/16686 |
| 01/09/1997 | WO1997000894A1 Compounds with growth hormone releasing properties |
| 01/09/1997 | WO1997000892A2 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/09/1997 | WO1997000891A1 Methods for treatment and prevention of diabetes |